Clinical Cancer Drugs


Giulio Francia
Department of Biological Sciences
The University of Texas
El Paso, TX

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 7 Issue: 2, October 2020

Meet Our Editorial Board Member free to download

Volume:7   Issue: 2
Pp: 63-63
H.B. Newton
DOI: 10.2174/2212697X0702200923121929
Published on: 23 September, 2020

Editorial free to download

Volume:7   Issue: 2
Pp: 64-64
Giulio Francia
DOI: 10.2174/2212697X0702200923143757
Published on: 23 September, 2020

MiRNAs: A New Approach to Predict and Overcome Resistance to Anticancer Drugs

Volume:7   Issue: 2
Pp: 65-77
Noor Altaleb*
DOI: 10.2174/2212697X07666200130092419
Published on: 29 January, 2020

Sphingosine Analogs and Protein Phosphatase 2A as a Molecular Targeted Cancer Therapy: A Mini Systematic Review

Volume:7   Issue: 2
Pp: 78-88
Thomas Mayerhofer and Rajesh Kumar Jha*
DOI: 10.2174/2212697X07999200504110631
Published on: 04 May, 2020

Does the Oxazolidinone Derivatives Constitute a Functional Approach for Cancer Therapy?

Volume:7   Issue: 2
Pp: 95-106
Eduardo Augusto Vasconcelos de Freitas Ramalho*, Marina Galdino da Rocha Pitta, Hernando de Barros Siqueira Neto and Ivan da Rocha Pitta
DOI: 10.2174/2212697X07999200807210936
Published on: 07 August, 2020

A Maximum Entropy Estimator for the Average Survival Time Differences between Two Groups

Volume:7   Issue: 2
Pp: 107-112
Marian Manciu*, Sorour Hosseini and Joscelyne Guzman-Gonzalez
DOI: 10.2174/2212697X07999200331120654
Published on: 31 March, 2020

Alsevirone-NF Reduces Serum Testosterone and Inhibits Prostate Cancer Xenograft Growth in Balb/c Nude Mice

Volume:7   Issue: 2
Pp: 113-118
Vadim S. Pokrovsky*, Vladimir A. Zolottsev, Alexandra S. Latysheva, Vasiliy A. Kudinov, Natalia Yu Anisimova, R.L.M. Almanza, Olga Yu Alekseeva, Konstantin K. Baskaev, Galina B. Smirnova, Yulia A. Borisova and Olga M. Ipatova
DOI: 10.2174/2212697X07999200511082225
Published on: 10 May, 2020

The Association Between the Level of Leukemic Stem Cells and Treatment Response Among Chronic Myeloid Leukemia Patients Treated with Imatinib Mesylate open access plus

Volume:7   Issue: 2
Pp: 119-124
Shinta Oktya Wardhani*, Hani Susianti, Puji Rahayu and Yuyun Yueniwati
DOI: 10.2174/2212697X07999200824115628
Published on: 24 August, 2020

A Phase I Study of OMN54 (Aneustat™) in Patients with Advanced Malignancies open access plus

Volume:7   Issue: 2
Pp: 125-132
Karen A. Gelmon*, Christian Kollmannsberger, Stephen Chia, Anna V. Tinker, Teresa Mitchell, Stephen Lam, Teresa Joshi, David Kwok, John Ostrem, Simon Sutcliffe and Daniel J. Renouf
DOI: 10.2174/1574893615999200601130946
Published on: 01 June, 2020

Acknowledgements to Reviewers free to download

Volume:7   Issue: 2
Pp: 133-133

DOI: 10.2174/2212697X0702201106120259
Published on: 06 November, 2020